Vuong Trieu - 23 Aug 2024 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Issuer symbol
OTLC
Transactions as of
23 Aug 2024
Transactions value $
$10,000
Form type
4
Filing time
27 Aug 2024, 08:00:06 UTC
Previous filing
30 Jun 2023
Next filing
26 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $10,000 +500,000 +0.54% $0.0200 92,544,217 23 Aug 2024 Direct
holding OTLC Common Stock 16,780,384 23 Aug 2024 By Autotelic, Inc.
holding OTLC Common Stock 6,872,529 23 Aug 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On August 23, 2024, Dr. Trieu purchased 500,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.02.